The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Change in anything is often met with trepidation but change often brings opportunities. During this session we will review the fundamentals of value based care and how it compares to the current reimbursement environment for FQHC’s. We will also discuss the financial implications of value-based care and share how proposed changes can be a win-win for both patients and your financial statements. A discussion will occur on staffing priorities for value-based care along with financial opportunities and some pitfalls to avoid during the transition..
The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities…
In addition to step-by-step instruction on how to fill out and file the Federal Financial Report (FFR Form 425), this session also provides an outline that includes an understanding of its purpose and guidance on the information collected on the FFR form…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.